Delivery Order SPE2DB22D3016-SPE2DB25FAYZ2
Award Date
6/10/25
Potential Completion Date
6/11/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,680.23, is for the delivery of 4,567,781,423 units of Cetirizine HCL 10 mg tablets. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 4,564,415,916 units of Cetirizine HCL 5 mg tablets in 100-count bottles. The contract has a firm fixed price of $2,826.93 and a period of performance ending on April 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit prime contractor. The contract is for the supply of 4,563,948,129 units of Cetirizine HCL 5 mg tablets in 100-count bottles, with a ceiling value of $1,242.40 and a period of performance through March 14, 2024. The contract was awarded as a stand-alone delivery order, not under any designated set-aside program. AmerisourceBergen Drug Corp's Corporate Office...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,610 units of Cetirizine HCl 5 mg tablets, a common antihistamine medication, with a total ceiling value of $1,828.57. The contract is a Firm Fixed Price arrangement with a period of performance through March 19, 2025. This Delivery Order appears to be part of a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cetirizine Hydrochloride 5 mg tablets. The contract has a ceiling value of $16,241.24 and is a firm fixed price award without a set-aside designation, indicating open competition. The ultimate completion date is June 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,561,071,183 units of Cetirizine HCL 10 mg tablets. The $4,535.85 firm-fixed-price contract has a completion date of May 30, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,726.63, is for the delivery of 4,567,410,467 units of Cetirizine HCL 10 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of February 28, 2025. The contract was awarded on February 27, 2025 and does not have a set-aside designation. AmerisourceBergen Drug Corp...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a wholly owned subsidiary of Amerisourcebergen Corporation. The contract is to provide 4,563,617,307 units of the pharmaceutical product Cetirizine Hydrochloride 5 mg Tablet, packaged in 100s, with a potential value of $1,734.83 and a completion date of February 12, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to...
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, valued at $1,172.53. The order is for 4,560,567,361 units of Cetirizine HCl 10 mg tablets, a generic antihistamine medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This...
This federal contract award, valued at $4,702.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,073,284 units of Cetirizine HCL 10 mg tablets, a prescription medication, with a completion date of April 30, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...